290
Views
25
CrossRef citations to date
0
Altmetric
Theme: Diabetes – Review

Understanding the impact of hypoglycemia on the cardiovascular system

, , , &
Pages 21-33 | Received 16 Feb 2016, Accepted 20 Dec 2016, Published online: 05 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yu-Shan Chang, Liang-Yi Lee & I-Te Lee. (2021) Variability in Annual Fasting Glucose and the Risk of Peripheral Artery Disease in Patients with Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity 14, pages 4109-4119.
Read now

Articles from other publishers (24)

Mengyao Li, Yanan Wan, Zheng Zhu, Pengfei Luo, Hao Yu, Jian Su, Dong Hang, Yan Lu, Ran Tao, Ming Wu, Jinyi Zhou & Xikang Fan. (2023) Association between glycated haemoglobin and the risk of chronic obstructive pulmonary disease: A prospective cohort study in UK biobank . Diabetes, Obesity and Metabolism 25:12, pages 3599-3610.
Crossref
Zihuan Zeng, Xingli Wang, Yanhan Chen, Hengyu Zhou, Wenfen Zhu, Xiu Xiong, Jiao Tang & Qinghua Zhao. (2023) Health-related quality of life in Chinese individuals with type 2 diabetes mellitus: a multicenter cross-sectional study. Health and Quality of Life Outcomes 21:1.
Crossref
O. V. Svetlova & I. V. Gurieva. (2023) Innovative technologies in the management of diabetes mellitus: prevention of hypoglycemia. Meditsinskiy sovet = Medical Council 17:9, pages 89-95.
Crossref
Reni Mattathil. (2023) Hypoglycemia Management Using a Bundled Care Approach. Journal of Nursing Care Quality 38:2, pages 141-145.
Crossref
Sarah K. Adie, Scott W. Ketcham, Vincent D. Marshall, Nicholas Farina & Devraj Sukul. (2023) The association of glucose control on in-hospital mortality in the cardiac intensive care unit. Journal of Diabetes and its Complications 37:4, pages 108453.
Crossref
Meryem K. Talbo, Rémi Rabasa-Lhoret, Jean-François Yale, Tricia M. Peters & Anne-Sophie Brazeau. (2022) Are nocturnal hypoglycemia prevention strategies influenced by diabetes technology usage? A BETTER registry analysis. Diabetes Research and Clinical Practice 191, pages 110080.
Crossref
Kenichi Tanaka, Yosuke Okada, Keiichi Torimoto, Kosuke Nishio, Manabu Narisawa & Yoshiya Tanaka. (2022) Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose tolerance. Scientific Reports 12:1.
Crossref
Fazal Rahim, Xie Yan, Jawad Ali Shah, Nida Bibi, Zafar Ullah Khan, Shah Nawaz & Yao Ming. (2023) Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis. F1000Research 11, pages 773.
Crossref
Fazal Rahim, Xie Yan, Jawad Ali Shah, Nida Bibi, Zafar Ullah Khan, Shah Nawaz & Yao Ming. (2022) Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis. F1000Research 11, pages 773.
Crossref
Kosuke Inoue, Roch Nianogo, Donatello Telesca, Atsushi Goto, Vahe Khachadourian, Yusuke Tsugawa, Takehiro Sugiyama, Elizabeth Rose Mayeda & Beate Ritz. (2021) Low HbA1c levels and all-cause or cardiovascular mortality among people without diabetes: the US National Health and Nutrition Examination Survey 1999–2015. International Journal of Epidemiology 50:4, pages 1373-1383.
Crossref
Wael A. Alanazi, Naif O. Al‐Harbi, Faisal Imam, Mushtaq A. Ansari, Ali Alhoshani, Abdullah F. Alasmari, Fawaz Alasmari, Mohammed M. Alanazi & Nemat Ali. (2020) Role of carnitine in regulation of blood pressure (MAP/SBP) and gene expression of cardiac hypertrophy markers (α/β‐MHC) during insulin‐induced hypoglycaemia: Role of oxidative stress. Clinical and Experimental Pharmacology and Physiology 48:4, pages 478-489.
Crossref
Chun-Ting Yang, Kuan-Ying Li, Chen-Yi Yang, Huang-Tz Ou & Shihchen Kuo. (2021) A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes. Scientific Reports 11:1.
Crossref
Niki Katsiki, Kalliopi Kotsa, Anca P. Stoian & Dimitri P. Mikhailidis. (2020) Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes. Current Pharmaceutical Design 26:43, pages 5637-5649.
Crossref
Majid Mobasseri, Masoud Shirmohammadi, Tarlan Amiri, Nafiseh Vahed, Hossein Hosseini Fard & Morteza Ghojazadeh. (2020) Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promotion Perspectives 10:2, pages 98-115.
Crossref
I-Te Lee. (2020) Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease. Diabetes and Vascular Disease Research 17:3, pages 147916412090903.
Crossref
Felix Aberer, Peter N. Pferschy, Norbert J. Tripolt, Caren Sourij, Anna M Obermayer, Florian Prüller, Eva Novak, Philipp Reitbauer, Harald Kojzar, Barbara Prietl, Selina Kofler, Martina Brunner, Eva Svehlikova, Tatjana Stojakovic, Hubert Scharnagl, Abderrahim Oulhaj, Faisal Aziz, Regina Riedl & Harald Sourij. (2019) Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study. Diabetes, Obesity and Metabolism 22:2, pages 212-221.
Crossref
David Fitchett, Silvio E Inzucchi, Christoph Wanner, Michaela Mattheus, Jyothis T George, Ola Vedin, Bernard Zinman & Odd Erik Johansen. (2020) Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial. European Heart Journal 41:2, pages 209-217.
Crossref
Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Seon-Ah Cha, Yu-Bae Ahn & Seung-Hyun Ko. (2019) Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study. Cardiovascular Diabetology 18:1.
Crossref
Susan Ghazi, Marcello Polesel & Andrew M. Hall. (2019) Targeting glycolysis in proliferative kidney diseases. American Journal of Physiology-Renal Physiology 317:6, pages F1531-F1535.
Crossref
Petar M Seferović & Pardeep S Jhund. (2019) Physiological monitoring of the complex multimorbid heart failure patient – diabetes and monitoring glucose control. European Heart Journal Supplements 21:Supplement_M, pages M20-M24.
Crossref
Qingjie Mu, Jing Zhu, Yanhong Si, Xiaofeng Chen, Guangqing Duan, Shiyu Sun, Guofeng Fang, Yongqing Zeng & Nana Yang. (2019) Overexpression of PID1 reduces high density lipoprotein level and functionality in swine. IUBMB Life 71:12, pages 1946-1951.
Crossref
Victor Sokolov, Tatiana Yakovleva, Shinya Ueda, Joanna Parkinson, David W. Boulton, Robert C. Penland & Weifeng Tang. (2018) Urinary glucose excretion after dapagliflozin treatment: An exposure‐response modelling comparison between Japanese and non‐Japanese patients diagnosed with type 1 diabetes mellitus. Diabetes, Obesity and Metabolism 21:4, pages 829-836.
Crossref
Mercedes Núñez, Silvia Díaz, Tatiana Dilla, Jesús Reviriego & Antonio Pérez. (2019) Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy 10:2, pages 375-392.
Crossref
Ryan Toedebusch, Anthony Belenchia & Lakshmi Pulakat. (2018) Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures. Frontiers in Physiology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.